Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruzzese

Showing results (761-770 of 766) with videos related to

Pageof 77
Sort By:
You have reached the last page of results.This site can display upto 766 results.
Scientific Reports|June 2, 2026
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World StudyAlessandro Conforti, Alarico Ariani, Martina Gentile, et al.
Rheumatology Advances in Practice|September 22, 2025
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre studyAndrea Becciolini, Antonio Marchesoni, Simone Parisi, et al.
Blood Advances|January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian CohortEnrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.
Rheumatology and Therapy|March 14, 2026
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic ArthritisValentino Paci, Alarico Ariani, Eleonora Celletti, et al.
Hematological Oncology|December 29, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World StudyErnesto Vigna, Enrica Antonia Martino, Annalisa Pitino, et al.
Acta Diabetologica|May 18, 2026
Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED Diabetes Study GroupBruno Bombaci, Marta Bassi, Valeria Castorani, et al.
Pageof 77

Showing results (761-770 of 766) with videos related to

Sort By:
Pageof 77
You have reached the last page of results.This site can display upto 766 results.
Scientific Reports|June 2, 2026
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World StudyAlessandro Conforti, Alarico Ariani, Martina Gentile, et al.
Rheumatology Advances in Practice|September 22, 2025
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre studyAndrea Becciolini, Antonio Marchesoni, Simone Parisi, et al.
Blood Advances|January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian CohortEnrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.
Rheumatology and Therapy|March 14, 2026
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic ArthritisValentino Paci, Alarico Ariani, Eleonora Celletti, et al.
Hematological Oncology|December 29, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World StudyErnesto Vigna, Enrica Antonia Martino, Annalisa Pitino, et al.
Acta Diabetologica|May 18, 2026
Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED Diabetes Study GroupBruno Bombaci, Marta Bassi, Valeria Castorani, et al.
Pageof 77